Astria Therapeutics Inc Newsroom

TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 20 07:33 ET

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $23 to $35

Moomoo NewsNov 15 08:03 ET

Astria Therapeutics Analyst Ratings

BenzingaNov 14 08:18 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsNov 14 06:31 ET

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsOct 24 15:31 ET

Astria Therapeutics Analyst Ratings

BenzingaSep 27 06:40 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsSep 27 06:33 ET

Evercore Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsSep 26 08:31 ET

TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsSep 25 18:31 ET

Evercore Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsAug 15 02:32 ET

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $16 to $35

Moomoo NewsAug 14 09:00 ET

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $16 to $35

Moomoo NewsAug 13 09:00 ET

Astria Therapeutics Analyst Ratings

BenzingaAug 13 07:13 ET

Astria Therapeutics Analyst Ratings

BenzingaJul 29 07:02 ET

TD Cowen Initiates Astria Therapeutics Inc(ATXS.US) With Buy Rating, Announces Target Price $35

Moomoo NewsJul 29 05:33 ET

Astria Therapeutics Analyst Ratings

BenzingaMay 21 08:03 ET

Astria Therapeutics Analyst Ratings

BenzingaMay 10 09:37 ET

Astria Therapeutics Analyst Ratings

BenzingaApr 23 06:22 ET

Astria Therapeutics Analyst Ratings

BenzingaMar 25 12:36 ET

Astria Therapeutics Analyst Ratings

BenzingaMar 14 07:14 ET